The Science of Substitution: A Response to Carrier and Minniti

University of Illinois Law Review Online, vol. 2018, pp. 81-92 (2018)

NYLS Legal Studies Research Paper No. 3093618

12 Pages Posted: 3 Jan 2018 Last revised: 12 Apr 2018

See all articles by Jacob S. Sherkow

Jacob S. Sherkow

New York Law School; Columbia University - Department of Health Policy and Management; Center for Advanced Studies in Biomedical Innovation Law

Date Written: March 31, 2018

Abstract

In Biologics: The New Antitrust Frontier, Michael A. Carrier and Carl J. Minniti provide an overview of potential antitrust harms in the newly enacted biologic drug approval and litigation regime, the Biologics Price Competition and Innovation Act (“BPCIA”). Importantly, Carrier and Minniti suggest that the scientific complexity of biologic products has the potential to make some litigation conduct that is typically anticompetitive more or less so, given uncertainties surrounding regulatory approval and patent infringement. This response advances Carrier and Minniti’s thesis, suggesting the authors do not take it far enough for their assessments of reverse payment settlements, submarine patenting, and citizen petition abuse. It also makes use of two important court decisions, Sandoz Inc. v. Amgen Inc., 137 S. Ct. 1664 (2017) and Amgen Inc. v. Sanofi, 872 F.3d 1367 (Fed. Cir. 2017) decided after Carrier and Minniti’s article went to press. Regardless of whether Carrier and Minniti’s predictions come to pass, their core insight—that scientific complexity can regulate antitrust harms—provides a key area of future exploration for practitioners, scholars, and policy makers alike.

Suggested Citation

Sherkow, Jacob S., The Science of Substitution: A Response to Carrier and Minniti (March 31, 2018). University of Illinois Law Review Online, vol. 2018, pp. 81-92 (2018); NYLS Legal Studies Research Paper No. 3093618. Available at SSRN: https://ssrn.com/abstract=3093618

Jacob S. Sherkow (Contact Author)

New York Law School ( email )

185 West Broadway
New York, NY 10013
United States
212.431.2355 (Phone)

HOME PAGE: http://www.nyls.edu/faculty/faculty-profiles/faculty_profiles/jacob-s-sherkow/

Columbia University - Department of Health Policy and Management ( email )

600 West 168th Street, 6th Floor
New York, NY 10032
United States

Center for Advanced Studies in Biomedical Innovation Law ( email )

Studiestraede 6
Studiestrade 6
Copenhagen, DK-1455
Denmark

HOME PAGE: http://jura.ku.dk/cebil/staff/

Register to save articles to
your library

Register

Paper statistics

Downloads
53
rank
371,410
Abstract Views
398
PlumX Metrics